The relationship between HbA1c and hypoglycaemia in patients with diabetes treated with insulin degludec versus insulin glargine 100 units/mL.

Athena Philis-TsimikasWendy LaneUlrik Pedersen-Bjergaard Carol H WyshamLars BardtrumSigne HarringSimon R Heller

Published in: Diabetes, obesity & metabolism (2020)

Our findings suggest that patients in clinical practice may be able to achieve lower glycaemia targets with degludec versus glargine U100, before incurring an equivalent risk of hypoglycaemia.

Keyphrases

type diabetes
glycemic control
clinical practice
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
insulin resistance
adipose tissue
weight loss